Gene · 3913
NIH grants2,633
NIH grants whose papers are about the gene, through NIH's grant-paper links.
781 to 800 of 2,633
Download this page as JSON| Grant | Title | LAMB2 papers | Newest fiscal year |
|---|---|---|---|
| R01CA078831 | Epigenetic regulation by tumor suppressor p53 | 1 | 2022 |
| R01CA109545 | Receptor Cross-Talk in Early Metastatic Dissemination | 1 | 2022 |
| R01CA151610 | The Role of FOXCI in Basal-like Breast Cancer | 1 | 2022 |
| R01CA166593 | Cell of Origin and the Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics | 1 | 2022 |
| R01CA221296 | The Role of Stromal Autophagy in Cutaneous Melanoma | 1 | 2022 |
| R01CA228524 | Targeting CXCR2 axis in Pancreatic Cancer | 1 | 2022 |
| R01CA235612 | Clinical Brain Tumor Development of a Cytomegalovirus-targeted Therapeutic with Vaccine pre-conditioning to Validate Novel Predictors of Vaccine Efficacy | 1 | 2022 |
| R01DE016289 | Mechanism of Cranial Neural Crest Cell Migration | 1 | 2022 |
| R01DE027329 | Elucidating Mechanism of Immune Evasion in Head and Neck Cancers | 1 | 2022 |
| R01DE027632 | A Peptide-Based Biomineralization Strategy for Tooth Repair | 1 | 2022 |
| R01DK047936 | Molecular Regulation of Muscle Glucose Metabolism in Man | 1 | 2022 |
| R01DK072301 | Genetic and Functional Studies of Human Ciliary Syndromes | 1 | 2022 |
| R01DK096096 | CFTR modulates innate immune response in biliary epithelium: Role in the pathogenesis and treatment of Cystic-Fibrosis-related liver disease. | 1 | 2022 |
| R01DK097598 | Juxta-glomerular cells serve as glomerular epithelial cell progenitors in glomerular disease | 1 | 2022 |
| R01DK116591 | miRNA Mechanism of Acute Kidney Injury in Aging | 1 | 2022 |
| R01DK119212 | Matrix receptors in chronic kidney disease | 1 | 2022 |
| R01EB023052 | Engineering a naturally derived and highly adhesive surgical sealant | 1 | 2022 |
| R01EB027143 | Programming immune function through modular assembly of polyionic immune signals | 1 | 2022 |
| R01EB027666 | Injectable Hydrogels to Protect Transplanted Cells from Hypoxia | 1 | 2022 |
| R01ES028114 | Mechanisms regulating the early stages of UV-induced skin cancer | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3913/grants?page=40